首页|90Y PET/CT和90Y韧致辐射SPECT/CT显像评估肝恶性肿瘤90Y-选择性内放射治疗后辐射剂量的对比

90Y PET/CT和90Y韧致辐射SPECT/CT显像评估肝恶性肿瘤90Y-选择性内放射治疗后辐射剂量的对比

Comparison of 90Y PET/CT and 90Y bremsstrahlung SPECT/CT imaging in evaluation of radiation dose after 90Y-selective internal radiation therapy in liver malignancies

扫码查看
目的 比较90Y PET/CT和90Y韧致辐射(BRS)SPECT/CT显像评估肝恶性肿瘤90Y-选择性内放射性治疗(SIRT)术后实际吸收剂量的差异,以及2种显像方式图像质量的优劣.方法 回顾性分析2021年9月至2022年8月在海南省肿瘤医院核医学科同时行90YPET/CT显像及90YBRS SPECT/CT显像的肝恶性肿瘤90Y-SIRT术后患者21例[男15例、女6例;年龄(52.4±15.4)岁;原发性肝癌15例,肝转移瘤6例;共39个病灶];分别计算90YPET/CT及90Y BRS SPECT/CT显像评估的肿瘤实际吸收剂量与肿瘤反应最低吸收剂量阈值(100 Gy)的比值,并对2种显像方式的图像对比度、可区分度评分,采用Wilcoxon符号秩检验和Wilcoxon秩和检验比较组间差异.结果 90YPET/CT 和90YBRS SPECT/CT 评估的肿瘤吸收剂量值分别为 143.94(55.91,233.48)Gy 和 107.82(53.59,157.53)Gy.24个病灶的90Y PET/CT评估值高于标准阈值,19个病灶的90Y BRS SPECT/CT评估值高于标准阈值.与90Y PET/CT相比,90YBRS SPECT/CT评估的肿瘤吸收剂量被低估[-24.25%(-32.32%,-12.14%)].90Y PET/CT、90Y BRS SPECT/CT评估的肿瘤实际吸收剂量与最低标准阈值的比值分别为 1.33(0.56,1.91)、0.97(0.47,1.25),差异有统计学意义(z=0.04,P<0.001).PET/CT 与 SPECT/CT图像对比度评分为0、1、2、3分的分别有2、2、12、23个病灶和2、3、16、18个病灶(z=-1.29,P=0.199);可区分度评分为0、1、2分的分别有3、15、21个病灶和4、32、3个病灶,差异有统计学意义(z=-2.79,P=0.005).结论 对于肝恶性肿瘤90Y-SIRT术后患者,90Y PET/CT显像在肿瘤吸收剂量评估和图像上病灶区分度方面要优于90YBRS SPECT/CT显像.
Objective To compare the differences of actual absorbed doses of liver malignant tumors after 90Y-selective internal radiation therapy(SIRT)evaluated by 90Y PET/CT and 90Y bremsstrahlung(BRS)SPECT/CT imaging,and to compare the image quality of the 2 imaging methods.Methods Twenty-one patients(15 males and 6 females;age:(52.4±15.4)years)with liver malignant tumors(15 cases of primary liver cancer,6 cases of liver metastases;39 lesions)between September 2021 and August 2022 were retrospectively analyzed.All patients underwent both 90Y PET/CT imaging and 90Y BRS SPECT/CT imaging in the Department of Nuclear Medicine,Hainan Cancer Hospital.The ratios of the actual absorbed doses based on 90Y PET/CT imaging and 90Y BRS SPECT/CT imaging to the lowest standard absorbed dose(100 Gy)for tumor response were calculated.The image contrast and distinguishability of the two imaging methods were scored.Wilcoxon signed rank test and Wilcoxon rank sum test were used for data analysis.Results The tumor absorbed doses evaluated by 90Y PET/CT and 90Y BRS SPECT/CT were 143.94(55.91,233.48)Gy and 107.82(53.59,157.53)Gy respectively.The doses evaluated by 90Y PET/CT were higher than the standard threshold in 24 lesions,while 19 lesions showed higher evaluated doses by 90Y BRS SPECT/CT than the standard threshold.Compared with 90Y PET/CT,90Y BRS SPECT/CT underestimated the tumor ab-sorbed dose of-24.25%(-32.32%,-12.14%).The ratio of dose evaluated by 90Y PET/CT to the lowest stand-ard threshold was 1.33(0.56,1.91),which was higher than that of dose evaluated by 90Y BRS SPECT/CT to the lowest standard threshold(0.97(0.47,1.25);z=0.04,P<0.001).PET/CT image contrast was scored 0,1,2,3 in 2,2,12,23 lesions respectively,and SPECT/CT image contrast was scored 0,1,2,3 in 2,3,16,18 lesions respectively(z=-1.29,P=0.199).The distinguishability scores of 0,1,2 based on PET/CT images were found in 3,15,21 lesions,while those based on SPECT/CT images were found in 4,32,3 lesions respectively(z=-2.79,P=0.005).Conclusion 90Y PET/CT imaging is supe-rior to 90Y BRS SPECT/CT imaging in radiation dose evaluation and tumor focus differentiation in patients with liver malignant tumors after 90Y-SIRT.

Liver neoplasmsBrachytherapyYttrium radioisotopesRadiation dosagePositron-emission tomographyTomography,X-ray computed

王玉君、于丽娟、潘登、熊亮、蒋海壮、陈璐

展开 >

海南省肿瘤医院核医学科,海口 570311

肝肿瘤 近距离放射疗法 钇放射性同位素 辐射剂量 正电子发射断层显像术 体层摄影术,X线计算机

海南省临床医学研究中心项目

LCYX202403

2024

中华核医学与分子影像杂志
中华医学会

中华核医学与分子影像杂志

CSTPCD北大核心
影响因子:1.107
ISSN:2095-2848
年,卷(期):2024.44(3)
  • 21